Dr. Erin Hamilton Spence: A Milestone in Lactation Medicine

Dr. Erin Hamilton Spence Achieves Esteemed Certification
Hamilton Spence sets a benchmark among neonatologists with her new credentials
Prolacta Bioscience, known for its dedication to enhancing the health of critically ill and premature infants, proudly announces that Dr. Erin Hamilton Spence, MD, IBCLC, FAAP, FABM, the director of clinical education and professional development, has been awarded board certification in breastfeeding and lactation medicine. This honor from the North American Board of Breastfeeding and Lactation Medicine (NABBLM) is a rare accomplishment, achieved by fewer than 100 physicians across North America.
The Significance of Certification
This esteemed designation boosts Dr. Hamilton Spence's capacity to advocate for the invaluable benefits of breast milk and further support Prolacta's dedicated donor community. The certification reflects her commitment to maintaining high standards for health care practice, specifically in breastfeeding and lactation medicine.
Promoting the Importance of Breast Milk
In the realm of neonatal care, Dr. Hamilton Spence applies her expertise by overseeing critical protocols that assess donor health risks. These measures are designed to ensure both quality and safety in Prolacta's human milk-based nutritional products. Here are three main ways these protocols emphasize donor and infant health:
- Aligning with global health recommendations to ensure that infants exclusively receive human milk for the first six months, facilitated through direct dialogue between healthcare providers and donors.
- Encouraging donors to categorize their milk donations according to health standards, minimizing risks by promoting voluntary separation of any milk that may have encountered illness or medication.
- Offering personalized support throughout the donation process, including guidance on safe handling and storage of milk to preserve its quality.
Prolacta is recognized for its proactive approach in implementing stringent safety measures, underscoring its commitment to protecting the fragile infants dependent on its nutritional fortifiers.
Advocating for Vulnerable Infants
Dr. Hamilton Spence expressed her admiration for Prolacta's donors, stating, "These extraordinary donors do not just nourish their children; they also contribute significantly by pumping, storing, and providing their surplus breast milk. Their altruism creates a lifeline for medically fragile infants who benefit immensely from human milk-based nutrition."
Experience in Neonatal Care
A highly respected neonatologist, Dr. Hamilton Spence has a proven track record in clinical leadership within top-tier neonatal intensive care units, including renowned centers. With her role as a medical expert at Prolacta, she actively educates hospital teams and neonatologists on improving health outcomes for premature infants through an Exclusive Human Milk Diet (EHMD).
"Dr. Hamilton Spence's multifaceted expertise uniquely positions her to leverage the power of breast milk in enhancing infant health," noted Scott Elster, CEO of Prolacta. "Her new certification not only acknowledges her professional commitment but also reinforces our organizational mission to support families with premature and critically ill newborns."
About Prolacta Bioscience
Prolacta Bioscience is a pioneering life sciences company committed to Advancing the Science of Human Milk to improve health outcomes for critically ill and premature infants. More than 100,000 extremely premature infants have benefitted from their human milk-based products, rigorously validated through numerous peer-reviewed studies. With state-of-the-art pharmaceutical-grade human milk processing facilities, Prolacta adheres to the highest standards in quality and safety, employing extensive screening protocols to protect nutritional integrity while ensuring pathogen inactivation.
Prolacta's mission continues to evolve as they dedicate themselves to research and advocacy, highlighting the life-saving power of human milk in neonatal care. To find out more, visit their official website and explore the vast range of initiatives designed to support vulnerable infants and their families.
Frequently Asked Questions
What does Dr. Erin Hamilton Spence's certification signify?
The certification indicates her specialized knowledge and commitment to breastfeeding and lactation medicine, enhancing her capacity to support infant health.
How does Prolacta support its donors?
Prolacta provides guidance on handling donations and implements risk assessment protocols to ensure the safety and quality of milk used in production.
What impact do Prolacta's products have on infants?
Prolacta's human milk-based products aim to improve health outcomes for critically ill and premature infants, offering essential nutrition tailored to their needs.
Why is human milk important for premature infants?
Human milk offers crucial nutrients and bioactive components that support growth and development, which are especially vital for premature infants.
How does Prolacta maintain quality in its products?
Prolacta employs rigorous safety standards and testing protocols in its manufacturing processes, ensuring only the highest quality human milk-based nutrition is delivered.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.